/TLX
TLX
Updated 25 May 08:16 am
$13.43
TELIX PHARMACEUTICALS LIMITED
1D+5.90%
1M+40.16%
1Y-54.37%
Track your position in TLX
Sign in to TradeLedgr to record trades in TLX (TELIX PHARMACEUTICALS LIMITED) with parcel-level precision and ATO-compliant reporting.
Recent Announcements
26 May 2026 6:50 AM
Becoming a substantial holder228KB
Becoming a substantial holder
21 May 2026 3:00 AM
Results of Annual General Meeting205KB
Results of Meeting
20 May 2026 11:39 PM
Telix Annual General Meeting Presentation2635KB
Company Presentation
20 May 2026 11:38 PM
Telix Annual General Meeting Chairman and CEO Addresses293KB
Chair's Address to Shareholders
13 May 2026 11:27 PM
App 3X Initial Director Interests - W Jellison284KB
Initial Director's Interest Notice
Fundamentals
P/E Ratio
-99999.99x
Div Yield
0.00%
EPS
$-0.0292
Avg Vol
2.9M
52W High
$27.400
52W Low
$8.260
Company Profile
Development and commercialising molecularly targeted radiation products for the treatment of cancer.
Corporate WebsiteFinancial History
2025A
$-7.1M profit
$803.8M rev
2024A
$33.7M profit
$516.6M rev
2023A
$4.2M profit
$333.0M rev